Elixinol Wellness (ASX:EXL) Gross-Profit-to-Asset % : 31.45% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Elixinol Wellness's annualized Gross Profit for the quarter that ended in Dec. 2023 was A$3.74 Mil. Elixinol Wellness's average Total Assets over the quarter that ended in Dec. 2023 was A$11.88 Mil. Therefore, Elixinol Wellness's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 31.45%.

Elixinol Wellness Gross-Profit-to-Asset % Historical Data

The historical data trend for Elixinol Wellness's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness Gross-Profit-to-Asset % Chart

Elixinol Wellness Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

11.37

8.15

14.44

16.68

27.15

Elixinol Wellness Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial							16.86	13.94	22.80	24.31	31.45

Competitive Comparison of Elixinol Wellness's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elixinol Wellness's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's Gross-Profit-to-Asset % falls into.

Elixinol Wellness Gross-Profit-to-Asset % Calculation

Elixinol Wellness's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	3.42	/	( (13.485	+	11.711)	/ 2 )
	=	3.42	/	12.598
	=	27.15 %

Elixinol Wellness's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	3.736	/	( (12.047	+	11.711)	/ 2 )
	=	3.736	/	11.879
	=	31.45 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Elixinol Wellness Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Elixinol Wellness (ASX:EXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

ELLXF:USA

Address

680 George Street, Level 12, Sydney, NSW, AUS, 2000

Website

https://www.elixinolwellness.com

Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines